V Adamo Selected Research

V Adamo Research Topics

Disease

10	Breast Neoplasms (Breast Cancer) 08/2013 - 08/2001
9	Neoplasms (Cancer) 08/2013 - 05/2006
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2011 - 09/2000
3	Colorectal Neoplasms (Colorectal Cancer) 11/2011 - 10/2005
2	Lung Neoplasms (Lung Cancer) 09/2017 - 02/2001
2	Disease Progression 08/2013 - 11/2002
2	Neoplasm Metastasis (Metastasis) 08/2013 - 08/2001
2	Brain Neoplasms (Brain Tumor) 04/2011 - 03/2006
1	Cardiotoxicity 08/2013
1	Triple Negative Breast Neoplasms 03/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2012
1	Inflammation (Inflammations) 11/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2011
1	Asthenia 04/2011
1	Leukopenia 01/2009
1	Prostatic Neoplasms (Prostate Cancer) 06/2008
1	Colonic Neoplasms (Colon Cancer) 06/2006
1	Ovarian Neoplasms (Ovarian Cancer) 11/2005
1	Ovarian Epithelial Carcinoma 11/2005
1	Ovarian Hyperstimulation Syndrome 09/2005
1	Transitional Cell Carcinoma 01/2005
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2005
1	Pain (Aches) 06/2004
1	Mucositis 04/2004
1	Squamous Cell Carcinoma of Head and Neck 04/2004
1	Retrograde Ejaculation 08/2003
1	Hepatitis C 08/2003
1	Thrombocytopenia (Thrombopenia) 02/2001
1	Anemia 02/2001
1	Fever (Fevers) 02/2001
1	Neutropenia 02/2001

Drug/Important Bio-Agent (IBA)

5	Gemcitabine FDA Link 06/2008 - 09/2000
3	Trastuzumab (Herceptin)FDA Link 08/2013 - 06/2007
3	Cisplatin (Platino)FDA LinkGeneric 04/2011 - 11/2002
3	Vinorelbine (Navelbine)FDA LinkGeneric 06/2008 - 02/2001
2	Pharmaceutical PreparationsIBA 08/2013 - 09/2005
2	Hormones (Hormone)IBA 08/2011 - 06/2008
2	Tamoxifen FDA LinkGeneric 06/2007 - 02/2005
2	DNA (Deoxyribonucleic Acid)IBA 06/2006 - 06/2006
2	PlatinumIBA 11/2005 - 11/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2005 - 04/2004
1	ErbB Receptors (EGF Receptor)IBA 09/2017
1	Tyrosine Kinase InhibitorsIBA 09/2017
1	Estrogen ReceptorsIBA 08/2013
1	Progesterone FDA LinkGeneric 03/2012
1	Epidermal Growth Factor (EGF)IBA 03/2012
1	Angiogenesis InhibitorsIBA 01/2012
1	CytokinesIBA 11/2011
1	Interleukin-23 (Interleukin 23)IBA 11/2011
1	fotemustine (Muphoran)IBA 04/2011
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2011
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2009
1	Leuprolide (Lupron)FDA LinkGeneric 12/2008
1	1-dodecylpyridoxal (PLD)IBA 06/2008
1	liposomal doxorubicin (Doxil)FDA Link 06/2008
1	thiamine triphosphorate (TTP)IBA 06/2008
1	Fulvestrant (Faslodex)FDA Link 06/2007
1	Aromatase InhibitorsIBA 06/2007
1	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2006
1	Biomarkers (Surrogate Marker)IBA 06/2006
1	Imatinib Mesylate (Gleevec)FDA Link 05/2006
1	Carboplatin (JM8)FDA LinkGeneric 11/2005
1	Fluorouracil (Carac)FDA LinkGeneric 10/2005
1	Leucovorin (Folinic Acid)FDA Link 10/2005
1	Cabergoline FDA LinkGeneric 09/2005
1	Goserelin (Zoladex)FDA Link 02/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2005
1	Analgesics (Analgesic Drugs)IBA 06/2004
1	RNA (Ribonucleic Acid)IBA 08/2003

Therapy/Procedure

8	Therapeutics 08/2013 - 05/2006
8	Drug Therapy (Chemotherapy) 11/2011 - 01/2005
3	Radiotherapy 04/2011 - 08/2001
2	Adjuvant Chemotherapy 01/2009 - 12/2008
1	Cytoreduction Surgical Procedures 01/2009
1	Hyperthermic Intraperitoneal Chemotherapy 01/2009
1	Pain Management 06/2004
1	Induction Chemotherapy 04/2004
1	Time-to-Treatment 11/2002
1	Erythrocyte Transfusion 02/2001